PYC 0.00% 10.5¢ pyc therapeutics limited

Ann: Phelan-McDermid Syndrome & CNS platform presentation, page-3

  1. 924 Posts.
    lightbulb Created with Sketch. 175
    This asset seems geared towards a partner deal - the ones with progressive milestones that runs into the $1+ billion + yearly royalties if the asset makes it to market.

    my 2 cents is that PYC should post this presentation on their LinkedIn while they are still BIO to help with awareness.

    Someone like Roche with more infrastructure/$ could help partner/accelerate this to market for the benefit of patients

 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $489.9M
Open High Low Value Volume
11.0¢ 11.0¢ 10.3¢ $190.9K 1.808M

Buyers (Bids)

No. Vol. Price($)
1 541363 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 226352 5
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
10.5¢
  Change
0.000 ( 4.55 %)
Open High Low Volume
11.0¢ 11.0¢ 10.3¢ 1733037
Last updated 15.59pm 14/06/2024 ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.